Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD

Bone Marrow Transplant. 2024 Mar;59(3):425-427. doi: 10.1038/s41409-023-02181-3. Epub 2024 Jan 5.

Zahra Hudda^{1

2}, Amanda Flannery³, Ashley Teusink-Cross^{3

4}, Stella M Davies^{3

5}, Pooja Khandelwal^{3

5}

¹ Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA. [email protected].
² Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, USA. [email protected].
³ Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
⁴ Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
⁵ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, 45229, USA.

No abstract available

Publication types